(CIDRAP News) As a result of a federal court ruling that stopped the US military's anthrax vaccination program last October, the Food and Drug Administration (FDA) is asking for public comments on its finding that the anthrax vaccine is safe and effective.
(CIDRAP News) The US Department of Defense (DoD) has asked for emergency authority to ignore a recent court ruling and resume vaccinating military personnel against anthrax because of what is described as an increased risk of attacks on US forces.
Editor's note: A correction was made in this story Nov 9 to make clear that the licensed anthrax vaccine does not contain the recombinant form of anthrax protective antigen.
(CIDRAP News) The Department of Health and Human Service (HHS) said last week that it plans to buy up to 5 million doses of the controversial anthrax vaccine currently used by the US military and put it in the national stockpile for civilian use.
Editor's note: A correction was made in this story Nov 9 to note that the existing licensed anthrax vaccine contains the natural rather than recombinant form of anthrax protective antigen.
(CIDRAP News) Federal health officials today announced the award of an $877 million contract for 75 million doses of a new anthrax vaccine to protect the public and improve on the existing vaccine used by the military.
(CIDRAP News) The Department of Defense (DoD) has suspended its anthrax vaccination program in response to a federal court ruling that military personnel should not have to accept the shots against their will unless the president orders them to do so.
(CIDRAP News) President Bush today signed the bill establishing Project BioShield, a $5.6 billion program to speed the development of drugs and vaccines to combat the effects of biological, chemical, nuclear, and radiological agents.
(CIDRAP News) The US House this week overwhelmingly approved the "BioShield" bill to guarantee a market for antidotes to biological and chemical weapons, thereby sending the legislation to President Bush for his promised signature.
(CIDRAP News) The Food and Drug Administration (FDA) last week approved the first generic versions of ciprofloxacin (Cipro), the antibiotic that drew national attention when it was used after the mail-borne anthrax attacks in 2001.
(CIDRAP News) The US Senate yesterday overwhelmingly passed "Project BioShield," a 10-year, $5.6 billion program to promote rapid development and use of drugs and vaccines to counter biological and chemical weapons.